Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: The purpose of this study was to evaluate the effects of prehypertensive losartan and amlodipine administration on left ventricular (LV) remodeling and function in spontaneously hypertensive rats-stroke prone (SHRSP).
Methods: Spontaneously hypertensive rats-stroke prone were prehypertensively administered losartan, amlodipine, or vehicle. Wistar-Kyoto rats were used as a control. Blood pressure of the rats was determined by tail-cuff method, and LV structure and function were measured by echocardiography and LV cannulation. Collagen volume fraction was analyzed by picrosirius red staining. Protein expressions of brain natriuretic peptide (BNP) and angiotensin II type 1 (AT1R) and type 2 (AT2R) receptors were determined by use of the Western blotting method.
Results: Although both drugs downregulated BNP protein expression, the LV remodeling and function were more improved with losartan than with amlodipine treatment. Losartan upregulated AT1R and downregulated AT2R protein expression.
Conclusions: Both drugs inhibited LV remodeling and improved LV function in prehypertensively treated SHRSP. Losartan provided better continued heart protection, potentially due to its persistent inhibition of AT1R and activation of AT2R in the myocardium.
Key Words: Amlodipine; Blood pressure; Heart; Losartan; Prehypertension.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804994 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Efficacy and Safety of Quadruple-Drug Fixed-Dose Single-Pill Combination Therapy for Hypertension and Dyslipidemia: A Prospective, Multicenter, Observational Study.
Clin Ther
August 2025
Cardiovascular Center, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea. Electronic address:
Purpose: Single-pill combination (SPC) therapy can reduce the pill burden in patients with hypertension and dyslipidemia, potentially improving medication adherence and clinical outcomes. This study aimed to evaluate the efficacy and safety of a quadruple-drug fixed-dose SPC (QFDC) therapy combining losartan, amlodipine, rosuvastatin, and ezetimibe (L/A/R/E) in these patients.
Methods: Between September 2021 and September 2023, 2,150 patients (mean age: 61.
A Case of Thiazide-Induced Hyponatremia in an Elderly Patient.
Cureus
June 2025
Internal Medicine, Aiken Regional Medical Centers, Aiken, USA.
In the dawn of the modern era, hypertension is still prevalent globally. Regardless of age and gender, thiazide diuretics, calcium channel blockers, and renin-angiotensin inhibitors remain the first line of treatment. Drug-induced hyponatremia is a side effect of thiazide diuretics.
View Article and Find Full Text PDFOverdoses of widely used cardiovascular drugs calcium channel blockers and angiotensin receptor blockers cause severe hemodynamic instability. Timely management with hyperinsulinemia-euglycemia therapy, vasopressors, and calcium gluconate is critical. Enhanced clinical vigilance, prompt intervention, and long-term care, including psychological evaluation, are essential to address underlying factors and prevent recurrence of overdoses.
View Article and Find Full Text PDFAntiphospholipid syndrome presenting as isolated renal vein thrombosis: a case report and review of the literature.
J Med Case Rep
March 2025
Department of Pediatric Nephrology, The Kidney Centre Post Graduate Training Institute, 197/9, Rafiqui Shaheed Road, Karachi, 75530, Pakistan.
Background: Pediatric antiphospholipid syndrome is a rare systemic autoimmune disorder characterized by recurrent thrombotic events in the presence of antiphospholipid antibodies. Isolated right renal vein thrombosis resulting in a nonfunctional kidney is an uncommon manifestation of antiphospholipid syndrome. Here, we present our experience with antiphospholipid syndrome secondary to systemic lupus erythematosus.
View Article and Find Full Text PDFToward a personalized chronotherapy of blood pressure.
Biomed J
March 2025
Halberg Chronobiology Center, University of Minnesota, Minneapolis, MN, USA; Department of Chronomics and Gerontology, Tokyo Women's Medical University, Tokyo, Japan.
Background: A consensus regarding the optimal time to administer anti-hypertensive medications has not been reached. Possible differential effects of different anti-hypertensive drugs on the circadian pattern of blood pressure (BP) and differential responses of individual patients receiving the same treatment at different times of the day may partly account for the controversy.
Methods: Ambulatory blood pressure monitoring (ABPM) data available at 30-minute intervals for 7 days from previous studies are reanalyzed to compare the effect of five drugs (amlodipine, atenolol, captopril retard, long-acting carteolol, and nilvadipine) taken 1.